(Q34403404)

1 August 2017

1 reference

title

Placebo response in anxiety disorders (English)

1 reference

1 August 2017

0 references

M A Piercy

1

1 reference

1 August 2017

J J Sramek

series ordinal

2

1 reference

1 August 2017

N M Kurtz

series ordinal

3

1 reference

1 August 2017

N R Cutler

series ordinal

4

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 September 1996

1 reference

Annals of Pharmacotherapy

1 August 2017

1 reference

1 August 2017

30

1 reference

1 August 2017

1013-1019

1 reference

1 August 2017

9

1 reference

The importance of placebo effects in pain treatment and research

1 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000917

Placebo effects in psychiatry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000917

Placebo response, placebo effect, and two attributes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000917

The natural history of anxiety disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000917

The Clinical Course and Long-Term Management of Generalized Anxiety Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000917

Anxiety and muscle tension as consequences of caffeine withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000917

Theoretical and therapeutic considerations for the anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000917

Drug treatment of panic disorder: early response to treatment as a predictor of final outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000917

Patterns of response during placebo treatment of panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000917

Pilot study of a CCKB antagonist in patients with panic disorder: preliminary findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000917

Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000917

Pharmacotherapy of Social Phobia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000917

Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000917

Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000917

Review of the use of pattern analysis to differentiate true drug and placebo responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000917

10.1177/106002809603000917

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference